Skip to content

Doximity DOCS Proceeds from exercises of stock options and other stock issuances

Proceeds from exercises of stock options and other stock issuances at other companies

McKesson logo
McKessonMCK
$24M-14.3%
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG
Cognizant logo
CognizantCTSH
Genpact logo
GenpactG

Other financials

Income statement

See full
Revenue$145.4M+5.1%
Gross profit$126.0M+1.7%
Operating income$24.8M-49.0%
Net income$19.1M-69.4%
EPS (diluted)$0.10-67.7%

Balance sheet

See full
Cash & equivalents$219.2M+4.6%
Total debt$10.2M-17.8%
Total equity$950.8M-12.2%
Total assets$1.1B-11.1%

Cash flow

See full
Operating cash flow$109.5M+11.2%
CapEx-
Free cash flow$81.6M-17.1%

Valuation

See full
Market cap$3.75B-60.5%

Profitability

See full
Gross margin89.1%-1.1pp
Operating margin33.3%-6.6pp
Net margin30.4%-8.7pp
FCF margin50.6%+2.7pp

Returns & leverage

See full
Return on equity19.3%-3.2pp
Debt / equity0.0×
Current ratio6.1×-0.9×

Where this comes from

Reported directly by Doximity in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions.

The official record: Doximity’s 10-K, filed May 19, 2026, on SEC EDGAR. View the filing →

Ask your AI about Doximity's proceeds from exercises of stock options and other stock issuances.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Doximity's proceeds from exercises of stock options and other stock issuances?
Doximity (DOCS) reported proceeds from exercises of stock options and other stock issuances of $2.77M in Q1 2026.
How has Doximity's proceeds from exercises of stock options and other stock issuances changed year-over-year?
Doximity's proceeds from exercises of stock options and other stock issuances decreased by 52.5% year-over-year, from $5.83M to $2.77M.
What is the long-term trend for Doximity's proceeds from exercises of stock options and other stock issuances?
Over 4 years (2022 to 2026), Doximity's proceeds from exercises of stock options and other stock issuances has grown at a -6.2% compound annual growth rate (CAGR), from $12.61M to $9.78M.